CORCEPT THERAPEUTICS INC ($CORT)
Filing Information
| Accession Number | 0001193125-26-330668 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 3, 2026 |
| Document | View SEC Filing |
Transactions
15
Total Shares
240,000
Total Value
$11,021,908.87
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Jul 30, 2026 | Exercise/Conversion | 80,000 | $23.06 | $1,844,800.00 | 96,130 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jul 30, 2026 | Sale | 4,200 | $105.54 | $443,247.84 | 91,930 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jul 30, 2026 | Sale | 8,956 | $106.96 | $957,891.67 | 82,974 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jul 30, 2026 | Sale | 400 | $108.46 | $43,384.00 | 82,574 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jul 30, 2026 | Sale | 2,202 | $110.03 | $242,282.32 | 80,372 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jul 30, 2026 | Sale | 600 | $110.95 | $66,570.00 | 79,772 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jul 30, 2026 | Sale | 4,700 | $113.18 | $531,940.83 | 75,072 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jul 30, 2026 | Sale | 15,477 | $114.96 | $1,779,237.47 | 59,595 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jul 30, 2026 | Sale | 14,222 | $115.87 | $1,647,859.05 | 45,373 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jul 30, 2026 | Sale | 7,089 | $116.96 | $829,101.79 | 38,284 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jul 30, 2026 | Sale | 8,267 | $117.93 | $974,951.28 | 30,017 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jul 30, 2026 | Sale | 4,783 | $118.73 | $567,907.59 | 25,234 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jul 30, 2026 | Sale | 8,103 | $119.95 | $971,939.45 | 17,131 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jul 30, 2026 | Sale | 1,001 | $120.67 | $120,795.57 | 16,130 | Direct | โ | View Details | |
Chief Financial Officer | Stock option (right to buy) | Derivative | Jul 30, 2026 | Exercise/Conversion | 80,000 | $0.00 | $0.00 | 95,833 | Direct | โ | View Details |